Drug Registration and Acceptance

Drug Name

Exact

Active Ingredient

Acceptance No.

Manufacturers

Acceptance Date

Status Date

Classification

Review Status

Drug Type

Submission

Evaluation Conclusion

ATC Category

Special Approval Varieties

Task Type

Major Special Varieties

Sequence No.

Stock Code

Visualized Analysis Export Evaluation Conclusion Evaluation Progress

Acceptance No.	Drug Name	Active Ingredient	Dosage Form	Classification	Submission	Acceptance Date	Manufacturers	Manufacturers	Review Status	Status Date	View
JXSL1900150	纳武利尤单抗注射液	Nivolumab	Injection	Biological Products	Import Drug Application	2019-12-21		Bristol-Myers Squibb Company	In Review	2019-12-20	view
JYSB2300210	纳武利尤单抗注射液	Nivolumab	Injection	Biological Products	Supplementary Application	2023-12-09					view
JXSS2101020	纳武利尤单抗注射液	Nivolumab	Injection	Biological Products(3.1)	Import Drug Application	2021-09-15					view
JXSL2000061	纳武利尤单抗注射液	Nivolumab	Injection	Biological Products	Import Drug Application	2020-05-30		Bristol-Myers Squibb Company	In Review	2020-05-29	view
JXSS1900038	纳武利尤单抗注射液	Nivolumab	Injection	Biological Products	Import Drug Application	2019-07-03			Certificate Issued	2020-03-12	view
JXSS2400059	纳武利尤单抗注射液	Nivolumab	Injection	Biological Products(2.2)	Import Drug Application	2024-07-17					view
JXSB2101075	纳武利尤单抗注射液	Nivolumab	Injection	Biological Products	Supplementary Application	2021-10-22					view
JXSL2000151	纳武利尤单抗注射液	Nivolumab	Injection	Biological Products(2.2)	Import Drug Application	2020-09-14		Bristol-Myers Squibb Company	In Review	2020-09-11	view
JYSB1900287	纳武利尤单抗注射液	Nivolumab	Injection	Biological Products	Supplementary Application	2019-10-18			In Review	2019-10-17	view
JYSB2101135	纳武利尤单抗注射液	Nivolumab	Injection	Biological Products	Supplementary Application	2021-09-15					view
JYSB2100071	纳武利尤单抗注射液	Nivolumab	Injection	Biological Products	Supplementary Application	2021-03-11	百时美施贵宝（中国）投资有限公司	BRISTOL-MYERS Squibb (CHINA) Co Ltd	Certificate Issued	2021-11-18	view
JXSL2000010	纳武利尤单抗注射液	Nivolumab	Injection	Biological Products	Import Drug Application	2020-01-21		Bristol-Myers Squibb Company	In Review	2020-01-20	view
JXSS1900001	纳武利尤单抗注射液	Nivolumab	Injection	Biological Products	Import Drug Application	2019-02-11			Certificate Issued	2019-10-15	view
JXSS2400015	纳武利尤单抗注射液	Nivolumab	Injection	Biological Products(2.2)	Import Drug Application	2024-02-24					view
JXSS2101027	纳武利尤单抗注射液	Nivolumab	Injection	Biological Products(3.1)	Import Drug Application	2021-10-29					view
JYSB2000327	纳武利尤单抗注射液	Nivolumab	Injection	Biological Products	Supplementary Application	2020-07-04			Certificate Issued	2020-08-11	view
JXSL1900069	纳武利尤单抗注射液	Nivolumab	Injection	Biological Products	Import Drug Application	2019-08-24		Bristol-Myers Squibb Company	In Review	2019-08-23	view
JXSS2400091	纳武利尤单抗注射液	Nivolumab	Injection	Biological Products(3.1)	Import Drug Application	2024-10-13					view
JXSS2101019	纳武利尤单抗注射液	Nivolumab	Injection	Biological Products(3.1)	Import Drug Application	2021-09-15					view
JXSS2000066	纳武利尤单抗注射液	Nivolumab	Injection	Biological Products(2.2)	Import Drug Application	2020-12-25	百时美施贵宝（中国）投资有限公司	BRISTOL-MYERS Squibb (CHINA) Co Ltd	Certificate Issued	2021-08-31	view